Wolchko J Scott 4

4 · FATE THERAPEUTICS INC · Filed Jul 25, 2022

Form 4

Period: 2022-07-21

See Remarks

Transactions

Exercise/Conversion
Common Stock
2022-07-21$2.70/sh+30,000$81,000→ 461,546 total
Sale
Common Stock
2022-07-21$33.07/sh−19,171$633,985→ 431,546 total
Sale
Common Stock
2022-07-21$32.54/sh−10,829$352,376→ 450,717 total
Exercise/Conversion
Common Stock
2022-07-22$2.70/sh+6,246$16,864→ 437,792 total
Sale
Common Stock
2022-07-22$33.28/sh−620$20,634→ 431,546 total
Sale
Common Stock
2022-07-22$31.33/sh−2,923$91,578→ 434,869 total
Sale
Common Stock
2022-07-22$32.61/sh−2,703$88,145→ 432,166 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-07-21−30,000→ 6,246 total
Exercise: $2.70Exp: 2027-01-03→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-07-22−6,246→ 0 total
Exercise: $2.70Exp: 2027-01-03→ Common Stock (6,246 underlying)

Footnotes (7)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
[F2]Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
[F3]Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share.
[F4]Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share.
[F5]Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share.
[F6]Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share.
[F7]This option is fully vested.

Documents

1 file